- €141.41m
- €162.94m
- €14.67m
2018 August 1st | 2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 29 W | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | GAS | GAS | GAS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 2.07 | 8.44 | 14.7 |
Cost of Revenue | |||||
Gross Profit | — | — | 2.2 | 4.44 | 9.57 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.048 | -0.008 | 5.61 | 17.1 | 27.5 |
Operating Profit | -0.048 | 0.008 | -3.54 | -8.62 | -12.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.078 | 0.008 | -3.57 | -8.71 | -13 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.078 | 0.008 | -3.57 | -8.7 | -13 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.078 | 0.008 | -3.57 | -8.7 | -13 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.078 | 0.008 | -3.57 | -8.7 | -13 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.01 | 0.808 | -1.21 | -0.372 | -0.505 |
Dividends per Share |